June 19, 2025
Social

Tokyo, Japan (June 19, 2025) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Shoji Hirashima), has awarded its 18th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.


Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation, and innovative research projects with expectations for future development are eligible for the award.


The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 11, 2025.

*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research and overseas studies for Japanese researchers.

Recipients of the 18th Japan Research Foundation for Clinical Pharmacology Research Award

Recipient

Organization

Research theme

Takayuki Ogino

Sanyo-Onoda City University
Faculty of Pharmaceutical Sciences, Division of Pharmaceutics

Developing novel therapeutic approaches targeting autophagy for inflammatory bowel disease

 

 

Kenshi Takeuchi

Matsuyama University
Department of Drug Information Analysis  College of pharmaceutical Sciences

Prophylactic drugs for oxaliplatin-induced peripheral neuropathy using real world data

Masahide Fukudo

Sapporo Medical University Hospital
Department of Pharmacy
Building real-world evidence to optimize treatment with therapeutic monoclonal antibodies based on pharmacokinetic and immunogenicity assessment

Koya Fukunaga

RIKEN Center for Integrative Medical Sciences

 

The establishment of large-scale database for the biomarkers of PGx-related genes in 13 populations

Kazuhiro Yamamoto

Okayama University
Department of Integrated Clinical and Basic Pharmaceutical Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences

Evaluation of adverse reactions and pharmacokinetics of fentanyl in neonates: A physiologically based pharmacokinetic modeling and simulation approach